Literature DB >> 24416529

Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Nico van Zandwijk, Christopher Clarke, Douglas Henderson, A William Musk, Kwun Fong, Anna Nowak, Robert Loneragan, Brian McCaughan, Michael Boyer, Malcolm Feigen, David Currow, Penelope Schofield, Beth Ivimey Nick Pavlakis, Jocelyn McLean, Henry Marshall, Steven Leong, Victoria Keena, Andrew Penman.   

Abstract

Entities:  

Year:  2013        PMID： 24416529      PMCID： PMC3886874          DOI： 10.3978/j.issn.2072-1439.2013.11.28

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  318 in total

1.  Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.

Authors:  R T Heelan; V W Rusch; C B Begg; D M Panicek; J F Caravelli; C Eisen
Journal:  AJR Am J Roentgenol       Date:  1999-04       Impact factor: 3.959

2.  Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.

Authors:  V W Rusch; E S Venkatraman
Journal:  Ann Thorac Surg       Date:  1999-11       Impact factor: 4.330

3.  Mesothelioma--VATS biopsy and lung mobilization improves diagnosis and palliation.

Authors:  M W Grossebner; A A Arifi; M Goddard; A J Ritchie
Journal:  Eur J Cardiothorac Surg       Date:  1999-12       Impact factor: 4.191

4.  Pleuropneumonectomy in the treatment of malignant pleural mesothelioma.

Authors:  S C Grondin; D J Sugarbaker
Journal:  Chest       Date:  1999-12       Impact factor: 9.410

5.  The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis.

Authors:  P M Cury; D N Butcher; B Corrin; A G Nicholson
Journal:  J Pathol       Date:  1999-10       Impact factor: 7.996

Review 6.  Mesothelioma: cases associated with non-occupational and low dose exposures.

Authors:  G Hillerdal
Journal:  Occup Environ Med       Date:  1999-08       Impact factor: 4.402

7.  Malignant mesothelioma due to environmental exposure to erionite: follow-up of a Turkish emigrant cohort.

Authors:  M Metintas; G Hillerdal; S Metintas
Journal:  Eur Respir J       Date:  1999-03       Impact factor: 16.671

8.  Percutaneous cervical cordotomy for the control of pain in patients with pleural mesothelioma.

Authors:  M B Jackson; D Pounder; C Price; A W Matthews; E Neville
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

9.  Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura--a single-institution experience with 189 patients.

Authors:  L de Graaf-Strukowska; J van der Zee; W van Putten; S Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-02-01       Impact factor: 7.038

10.  Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura.

Authors:  P M Cury; D N Butcher; C Fisher; B Corrin; A G Nicholson
Journal:  Mod Pathol       Date:  2000-02       Impact factor: 7.842
View more
  77 in total

Review 1.  Malignant pleural mesothelioma: an update on diagnosis and treatment options.

Authors:  Sanjana Kondola; David Manners; Anna K Nowak
Journal:  Ther Adv Respir Dis       Date:  2016-02-12       Impact factor: 4.031

Review 2.  [Surgical therapy of malignant pleural mesothelioma].

Authors:  M Schirren; S Sponholz; S Oguzhan; A Fisseler-Eckhoff; A Fischer; J Schirren
Journal:  Chirurg       Date:  2016-05       Impact factor: 0.955

Review 3.  Overview of treatment related complications in malignant pleural mesothelioma.

Authors:  David J Murphy; Ritu R Gill
Journal:  Ann Transl Med       Date:  2017-06

Review 4.  MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets.

Authors:  Glen Reid
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

5.  Malignant pleural mesothelioma: key determinants in tailoring the right treatment for the right patient.

Authors:  Ori Wald; David J Sugarbaker
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

6.  MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma.

Authors:  Michaela B Kirschner; Yuen Yee Cheng; Nicola J Armstrong; Ruby C Y Lin; Steven C Kao; Anthony Linton; Sonja Klebe; Brian C McCaughan; Nico van Zandwijk; Glen Reid
Journal:  Mol Oncol       Date:  2014-12-02       Impact factor: 6.603

7.  Membranous nephropathy associated with malignant pleural mesothelioma in an adult patient: A case report.

Authors:  Xinyu Pu; Yanna Dou; Dong Liu; Shan Lu; Songxia Quan; Xiaoxue Zhang; Shuang Ma; Zhanzheng Zhao
Journal:  Mol Clin Oncol       Date:  2016-08-04

8.  A Novel Prospective Study Assessing the Combination of Photodynamic Therapy and Proton Radiation Therapy: Safety and Outcomes When Treating Malignant Pleural Mesothelioma.

Authors:  Stephanie R Rice; Yun R Li; Theresa M Busch; Michele M Kim; Sally McNulty; Andrea Dimofte; Timothy C Zhu; Keith A Cengel; Charles B Simone
Journal:  Photochem Photobiol       Date:  2018-12-28       Impact factor: 3.421

Review 9.  Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: a systematic review.

Authors:  Lisa Brusselmans; Lieselot Arnouts; Charissa Millevert; Joyce Vandersnickt; Jan P van Meerbeeck; Kevin Lamote
Journal:  Transl Lung Cancer Res       Date:  2018-10

Review 10.  The role of radical radiotherapy in the management of malignant pleural mesothelioma: A systematic review.

Authors:  Miranda Ashton; Noelle O'Rourke; Suzanne Currie; Andreas Rimner; Anthony Chalmers
Journal:  Radiother Oncol       Date:  2017-08-28       Impact factor: 6.280
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.